Synthetic HLA binding peptide analogues and uses thereof

Details for Australian Patent Application No. 2004294345 (hide)

Owner Sloan-Kettering Institute for Cancer Research

Inventors Pinilla-Ibarz, Javier; Scheinberg, David

Agent Griffith Hack

Pub. Number AU-B-2004294345

PCT Pub. Number WO2005/053618

Priority 60/525,955 01.12.03 US

Filing date 30 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 23 February 2012

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/053618 Priority application(s): WO2005/053618

23 February 2012 Application Accepted

  Published as AU-B-2004294345

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294348-Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal

2004294343-Treating infectious diseases using ICE inhibitors